Yatharth Hospital & Trauma Care Services Limited — Important, 27-01-2025: Financial Result Updates

**Consolidated Financial Summary:**

Yatharth Hospital & Trauma Care Services Limited reports a consolidated revenue from operations of ₹2,191.55 crore for the quarter ending December 31, 2024, reflecting a solid growth from ₹1,667.93 crore in the same period last year, translating to a year-over-year growth of 31.4%. This increase is attributed to higher patient inflow and expanded service offerings across its facilities.

The net profit for the quarter stands at ₹304.91 crore, showing a marginal decrease compared to ₹294.88 crore in the previous year, mainly due to rising operational costs, particularly in employee benefits expenses which increased to ₹426.15 crore. The Earnings Per Share (EPS) is reported at ₹3.57.

Total expenses for the quarter were ₹1,832.09 crore, up from ₹1,283.88 crore YoY, indicating a significant rise in operational costs, which increased by approximately 42.7%. Diligent cost management strategies in areas like procurement of medical consumables and workforce efficiency will be essential going forward.

The balance sheet remains healthy, with a steady cash position bolstered by recent funding initiatives, including a Qualified Institutional Placement (QIP) that raised approximately ₹6249.95 crore. This capital will support ongoing expansions and acquisitions.

Overall, Yatharth Hospital appears strategically positioned for future growth despite current challenges, merging operational efficiencies with new investments. Given the robust revenue growth and the health of the balance sheet, investors may consider a **buy** as the company capitalizes on both market expansion and service diversification.